the vaccine – Page 63 – Communicable Diseases Research

Host factors and vaccine efficacy: Implications for COVID‐19 vaccines

Review

Published on 2021-12-072022-11-01
Journal: Journal of medical virology [Category] COVID-19, COVID19(2023년), SARS,

COVID-19 Vaccine-Related Psychological Stress Among General Public in China

Psychiatry

Published on 2021-12-072022-10-31
Journal: Frontiers in Psychiatry [Category] COVID-19,

[키워드] addition affected allergy Analysis asked China Chronic diseases Complication concerning conducted COVID-19 COVID-19 epidemic COVID-19 infection COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine effective Efficacy evaluate event events Factor Final General public Government health knowledge help information Intervention Linear regression analysis management mental illness Multiple Multivariable regression analysis participant Participants promote Psychological Psychological stress Public public health public well-being significantly Stress stress level Symptoms the vaccine understanding vaccination Vaccine Vaccines was performed
[DOI] 10.3389/fpsyt.2021.774504 PMC 바로가기 [Article Type] Psychiatry

Blood donor eligibility after COVID-19 vaccination: the current state of recommendations

Review

Published on 2021-12-062022-10-28
Journal: The Pan African Medical Journal [Category] COVID-19, MERS, SARS,

Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults

건강한 성인을 대상으로 한 비활성화된 중증 급성 호흡기 증후군 코로나바이러스 2 백신에 대한 무작위, 이중 맹검, 위약 대조 2상 시험

Clinical Trial

Published on 2021-12-062022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 임상, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adverse reaction Adverse reactions anti-N antibodies anti-N antibody anti-S antibody clinical Controlled trial coronavirus coronavirus 2 dose double-blinded enrolled evaluated geometric mean geometric mean titer geometric mean titers GMT GMTs groups HD group healthy High dose immunization immunogenicity inactivated Inactivated SARS-CoV-2 vaccine medium dose neutralizing antibody Phase 2 phase 2 trial Randomized respiratory Safety safety analysis SARS-CoV-2 SARS-CoV-2 vaccine Serious Adverse Event Serious Adverse Events seroconversion rate seroconversion rates study period subject the vaccine Trial Vaccine
[DOI] 10.1093/cid/ciaa1703 PMC 바로가기 [Article Type] Clinical Trial

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines—Biology, Current Evidence and Recommendations

Supplement Articles

Published on 2021-12-052022-10-29
Journal: Journal of the Canadian Association of Gastroenterology [Category] COVID-19,

Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study

BNT162b2 mRNA COVID-19 백신에 대한 항체 반응의 역학: 7개월 추적 연구

Article

Published on 2021-12-052022-09-10
Journal: Medicina [Category] SARS, 진단, 치료기술,

[키워드] (Abbott Abbott acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 All study participants amplitude anti-spike protein IgG antibodies antibody Antibody Response BNT162b2 BNT162b2 mRNA BNT162b2 mRNA COVID-19 vaccine BNT162b2 mRNA vaccine booster dose CMIA Complete comprehension conducted coronavirus COVID-19 COVID-19 vaccine division Dynamics Follow-up healthcare Healthcare workers IgG immune response immune responses Immunity immunoassay individual individuals infected individual infected with SARS-CoV-2 Infection Ireland material median median titer Microparticle MONITOR participant Participants reported respiratory response Romania SARS-CoV-2 SARS-CoV-2 IgG II Quant assay second dose sensitivity Seven severe acute respiratory syndrome Coronavirus significantly higher Sligo specificity Spike protein study participant subject the antibody response the median the SARS-CoV-2 the vaccine two groups uninfected vaccinated individual vaccination Vaccine
[DOI] 10.3390/medicina57121330 PMC 바로가기 [Article Type] Article

Impact of vaccine prioritization strategies on mitigating COVID-19: an agent-based simulation study using an urban region in the United States

Covid-19 : 미국의 도시 지역을 이용한 에이전트 기반 시뮬레이션 연구에 대한 백신 우선 순위 화 전략의 영향

Research

Published on 2021-12-052022-09-10
Journal: BMC Medical Research Methodology [Category] Fulltext, SARS, 변종,

[키워드] a minor Agent-based simulation model approved calibrated circulation Community Comparisons Contact tracing COVID-19 cumulative death disease Efficacy eligible examined Face mask focus granular growth Hope Hospitalized hypothesis test Impact individuals Infection infections Intervention Isolation mimicking minor Moderna natural history no significant difference notable novel vaccines observation occurred pairwise comparisons pandemic parameter Pfizer/BioNTech prevented public health quarantine random reduce reduced reducing reported Result significantly spread of COVID-19 supplementary material susceptible the United State the vaccine the vaccines threshold vaccination Vaccination policies Vaccination prioritization Vaccination strategies Vaccine Vaccines variant Viral Viral transmission was used
[DOI] 10.1186/s12874-021-01458-9 PMC 바로가기 [Article Type] Research

Students’ Views on Vaccination against COVID-19 Virus and Trust in Media Information about the Vaccine: The Case of Serbia

Article

Published on 2021-12-032022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] age conducted consequence COVID-19 COVID-19 vaccinations COVID-19 virus dose favor had more immunization information investigated lowest mass media Novi Sad provided public health Republic of Serbia Research student students the vaccine Trust university vaccination Vaccine Vaccines View
[DOI] 10.3390/vaccines9121430 PMC 바로가기 [Article Type] Article

Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer A US Nationwide Veterans Affairs Study

암 환자의 SARS-CoV-2 감염과 COVID-19 예방 접종의 연관성 미국 전역 재향 군인 연구

Multicenter Study

Published on 2021-12-022022-09-10
Journal: JAMA Oncology [Category] COVID19(2023년), MERS, SARS, 치료기술,

[키워드] 1:1 95% CI Affair age association Cancer cancer type Care Chemotherapy Cohort cohort study Control controls COVID-19 COVID-19 vaccination death defined determine dose effective Effectiveness eligibility criteria eligible Endocrine Endocrine Therapy Ethnicity exposure finding first vaccination Follow-up for inclusion Health Health care Health care system hematologic Immunosuppressed Importance increased risk individuals Infection infection rate measure median multicenter objective outcomes participant Patient patients Patients with cancer Point positive result Primary outcome receipt receiving Relevance Result risk risk ratio risk reduction rurality SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 vaccination SARS-CoV-2 vaccine second dose serologic testing setting severe COVID-19 solid tumor solid tumors subgroup systemic therapy the vaccine therapy Treatment tumors vaccinated individual vaccinated individuals vaccination Vaccine vaccine dose vaccine response veteran white
[DOI] 10.1001/jamaoncol.2021.5771 PMC 바로가기 [Article Type] Multicenter Study

COVID-19 Vaccine Does Not Increase the Risk of Disease Flare-Ups among Patients with Autoimmune and Immune-Mediated Diseases

Article

Published on 2021-12-022022-10-30
Journal: Journal of Personalized Medicine [Category] COVID-19,